Shariah compliance overview
Not HalalAmylyx Pharmaceuticals, Inc. (AMLX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions.
Amylyx Pharmaceuticals, Inc. (AMLX) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 0.57%Limit 30%Pass
- Interest-bearing securities and assets
- 38.66%Limit 30%Fail
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Amylyx Pharmaceuticals, Inc. (AMLX). Current Akinda screening label: Not Halal.
